Leading Innovation in Blood Pressure

Josep and Mattia join the Swiss Centre for Electronics and Microtechnology (CSEM)

30+ techniques tested, 10+ studies conducted;
1 proven solution: Optical Blood Pressure Monitoring

His research on continuous non-invasive BP estimation is the technology behind Aktiia’s monitoring solutions.

Aktiia’s clinical trial, highlighted in Blood Pressure Monitoring journal, demonstrates its optical device’s accuracy in measuring blood pressure without cuffs, compared to traditional arterial line methods.

Aktiia’s trial successfully compares its cuffless BP monitoring technology against traditional auscultation methods, ensuring accuracy during posture changes. This supports the device’s use for consistent 24-hour blood pressure tracking.

Aktiia is classified as a Class IIa Medical Device, adhering to the highest safety and performance standards in the European Union.

Aktiia continues its expansion, offering its advanced health monitoring technologies to the UK audience.

Aktiia brings its cutting-edge solution to Germany, Switzerland, France, Italy, Austria and Ireland.

Published in Nature Scientific Reports, Aktiia’s study demonstrates the consistent accuracy of its wearable blood pressure monitor across different body positions.

Aktiia’s cuffless BP monitor is validated by a Nature Hypertension study, showing equivalent accuracy to 24-hour ambulatory monitoring in cardiac rehab patients.

Evaluating its performance in different body positions with auscultation as the reference measurement.

Aktiia’s blood pressure technology is at the forefront of medical innovation, participating in over 20 clinical trials worldwide to improve patient care and health outcomes.

Approval of the CALFREE™ technology sets the stage for Aktiia to transform BP monitoring and management.

We’re excited to announce the appointment of Raghav “Rags” Gupta as the new CEO. With a wealth of experience and a proven track record, Rags brings a dynamic leadership style that aligns perfectly with Aktiia’s mission to transform blood pressure monitoring and management globally.